India's pharmaceutical industry continues to dominate the global healthcare market despite fresh tariff concerns from the US. Gaurang Shah, Sr. VP, Geojit Investments, believes India will remain the "pharmacy to the world" for years due to its strong manufacturing capabilities, research, and product innovation. He advises investors to look beyond pharma manufacturers and also focus on hospitals and diagnostic companies, which together form the broader healthcare ecosystem.
Asian Paints Q1 show: MD & CEO Amit Syngle on price hike, rising competition, B2B business and more
Snapdragon 8 Elite Gen 5, 9,000 mAh battery and 200MP camera: Redmi K100 Pro’s leaked specs are amazing
From Odisha to Delhi: These states will see heavy rainfall as 2 weather systems merge
Maruti Suzuki starts production at fourth Gujarat plant, takes total annual capacity to 2.9 million units
Car ownership vs ride-hailing: Is buying a car still the smarter financial choice?Asian Paints Q1 show: MD & CEO Amit Syngle on price hike, rising competition, B2B business and more
Tata Steel Q1 results preview: Net profit may fall 3-7%, sales may grow in double digits
MTAR Technologies shares snap five-session losing streak, climb 5% after Q1 results, order update
Asian Paints outlook: Single-digit volume growth likely amid high competition, war effects 
Suzlon shares in bear grip: down 20% in July so far; analysts still see up to 60% upside
U.S. Fed Holds Rates, Inflation Fears Return: Gaurang Shah Explains Impact On Markets
Banking Stocks Outlook: Can Lower Costs And Strong Credit Growth Drive The Next Rally?
Top Sectors For FY27 Growth: Why IT, Banks, Defense And Power Could OutI.T. Set For Re-Rating? Why FY27 Could Be A Turning Point | Banks, Defence In Focusperform
FIIs Turning Positive On India After Massive Sell-Off? Ajay Bagga Explains The Flow Shift
How To Build The Perfect Mutual Fund Portfolio | Active Vs Passive Strategy Explained
